國立虎尾科技大學 |

Disruptive Psychopharmacology

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Disruptive Psychopharmacology / edited by Frederick S. Barrett, Katrin H. Preller.
other author:	Barrett, Frederick S.
Description:	VIII, 332 p. 100 illus., 30 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Neuropharmacology. -
Online resource:	https://doi.org/10.1007/978-3-031-12184-5
ISBN:	9783031121845

Disruptive Psychopharmacology
Disruptive Psychopharmacology [electronic resource] /edited by Frederick S. Barrett, Katrin H. Preller. - 1st ed. 2022. - VIII, 332 p. 100 illus., 30 illus. in color.online resource. - Current Topics in Behavioral Neurosciences,561866-3389 ;. - Current Topics in Behavioral Neurosciences,19.

Dosing psychedelics and MDMA -- Psychedelic Group Therapy -- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies -- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults -- Foundations for Training Psychedelic Therapists -- Ayahuasca for the Treatment of Depression -- Psilocybin for the Treatment of Depression -- Ketamine for the Treatment of Depression -- The Potential of Psychedelics for End of Life and Palliative Care -- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action -- Psilocybin for Tobacco Use Disorder -- Psychedelic Drugs as Anti-Inflammatory Agents -- Psilocybin for the Treatment of Obsessive-Compulsive Disorder -- Psilocybin for the Treatment of Headache and Pain Disorders -- Psilocybin for the Treatment of Neurodegenerative Disorders -- Psilocybin for Trauma-Related Disorders.

Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.

ISBN: 9783031121845

Standard No.: 10.1007/978-3-031-12184-5doiSubjects--Topical Terms:

677629
Neuropharmacology.

LC Class. No.: RM315-334

Dewey Class. No.: 615.78

Disruptive Psychopharmacology
LDR:03043nam a22004095i 4500 001 1082399
003 DE-He213
005 20220825211925.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783031121845 $9 978-3-031-12184-5
024 7 $a 10.1007/978-3-031-12184-5 $2 doi
035 $a 978-3-031-12184-5
050 4 $a RM315-334
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 615.78 $2 23
245 1 0 $a Disruptive Psychopharmacology $h [electronic resource] / $c edited by Frederick S. Barrett, Katrin H. Preller.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a VIII, 332 p. 100 illus., 30 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Topics in Behavioral Neurosciences, $x 1866-3389 ; $v 56
505 0 $a Dosing psychedelics and MDMA -- Psychedelic Group Therapy -- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies -- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults -- Foundations for Training Psychedelic Therapists -- Ayahuasca for the Treatment of Depression -- Psilocybin for the Treatment of Depression -- Ketamine for the Treatment of Depression -- The Potential of Psychedelics for End of Life and Palliative Care -- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action -- Psilocybin for Tobacco Use Disorder -- Psychedelic Drugs as Anti-Inflammatory Agents -- Psilocybin for the Treatment of Obsessive-Compulsive Disorder -- Psilocybin for the Treatment of Headache and Pain Disorders -- Psilocybin for the Treatment of Neurodegenerative Disorders -- Psilocybin for Trauma-Related Disorders.
520 $a Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.
650 0 $a Neuropharmacology. $3 677629
650 0 $a Psychiatry. $3 585488
650 0 $a Neurology . $3 1253459
650 2 4 $a Neurology. $3 593894
700 1 $a Barrett, Frederick S. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1388051
700 1 $a Preller, Katrin H. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1388052
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783031121838
776 0 8 $i Printed edition: $z 9783031121852
776 0 8 $i Printed edition: $z 9783031121869
830 0 $a Current Topics in Behavioral Neurosciences, $x 1866-3370 ; $v 19 $3 1253607
856 4 0 $u https://doi.org/10.1007/978-3-031-12184-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)